Dipongkor Saha

2.2k total citations · 1 hit paper
47 papers, 1.7k citations indexed

About

Dipongkor Saha is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Dipongkor Saha has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 23 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in Dipongkor Saha's work include Virus-based gene therapy research (33 papers), CAR-T cell therapy research (22 papers) and Viral gastroenteritis research and epidemiology (11 papers). Dipongkor Saha is often cited by papers focused on Virus-based gene therapy research (33 papers), CAR-T cell therapy research (22 papers) and Viral gastroenteritis research and epidemiology (11 papers). Dipongkor Saha collaborates with scholars based in United States, Belgium and Finland. Dipongkor Saha's co-authors include Samuel D. Rabkin, Robert L. Martuza, Hong-My Nguyen, Hans Nauwynck, Hiroaki Wakimoto, Praveen K. Bommareddy, David Lefebvre, Jan Van Doorsselaere, Liping Huang and Uladzimir Karniychuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Cell and Journal of Virology.

In The Last Decade

Dipongkor Saha

47 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade

2017 445 citations Dipongkor Saha, Robert L. Martuza et al. Cancer Cell profile →

Peers

Countries citing papers authored by Dipongkor Saha

Since Specialization

Citations

This map shows the geographic impact of Dipongkor Saha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipongkor Saha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipongkor Saha more than expected).

Fields of papers citing papers by Dipongkor Saha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dipongkor Saha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipongkor Saha. The network helps show where Dipongkor Saha may publish in the future.

Co-authorship network of co-authors of Dipongkor Saha

This figure shows the co-authorship network connecting the top 25 collaborators of Dipongkor Saha. A scholar is included among the top collaborators of Dipongkor Saha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dipongkor Saha. Dipongkor Saha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors 2025 ·Cancer Gene Therapy ·M’Liss A. Hudson, Robert H. Newman, Checo J. Rorie, (unknown), Howard L. Kaufman, Samuel D. Rabkin, Joseph L. Graves, Dipongkor Saha	2
2	Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy? 2024 ·Journal for ImmunoTherapy of Cancer ·(unknown), Mia C. Borlongan, Howard L. Kaufman, (unknown), Hans Nauwynck, Samuel D. Rabkin, Dipongkor Saha	13
3	Understanding the interplay between oHSV and the host immune system: Implications for therapeutic oncolytic virus development 2024 ·Molecular Therapy ·(unknown), Hiroaki Wakimoto, Hans Nauwynck, Howard L. Kaufman, Samuel D. Rabkin, Dipongkor Saha	4
4	Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival 2024 ·Journal for ImmunoTherapy of Cancer ·Praveen K. Bommareddy, Hiroaki Wakimoto, Robert L. Martuza, Howard L. Kaufman, Samuel D. Rabkin, Dipongkor Saha	25
5	A novel oncolytic HSV co-expressing IL-12 and anti-PD-1 for glioblastoma 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Dipongkor Saha	2
6	Emerging biologics for the treatment of pulmonary arterial hypertension 2023 ·Journal of drug targeting ·(unknown), (unknown), Dipongkor Saha, Tahmina Foyez, Fakhrul Ahsan	7
7	Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy 2023 ·Stem Cell Reviews and Reports ·Mia C. Borlongan, Dipongkor Saha, (unknown)	18
8	Pathogenetic Features and Current Management of Glioblastoma 2021 ·Cancers ·Hong-My Nguyen, (unknown), Devin B. Lowe, Dipongkor Saha	48
9	Optimal timing of PD-1 blockade in combination with oncolytic virus therapy 2021 ·Seminars in Cancer Biology ·Hong-My Nguyen, Praveen K. Bommareddy, Ann W. Silk, Dipongkor Saha	34
10	Combinatorial Effects of VEGFR Kinase Inhibitor Axitinib and Oncolytic Virotherapy in Mouse and Human Glioblastoma Stem-Like Cell Models 2018 ·Clinical Cancer Research ·Dipongkor Saha, Hiroaki Wakimoto, Cole W. Peters, (unknown), Samuel D. Rabkin, Robert L. Martuza	59
11	Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade breakdown → 2017 ·Cancer Cell ·Dipongkor Saha, Robert L. Martuza, Samuel D. Rabkin	445
12	Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma 2016 ·Molecular Therapy ·Mikko Siurala, Riikka Havunen, Dipongkor Saha, (unknown), Anu J. Airaksinen, Siri Tähtinen, Víctor Cervera-Carrascón, Simona Bramante, Suvi Parviainen, Markus Vähä‐Koskela, Anna Kanerva, Akseli Hemminki	43
13	Oncolytic herpes simplex virus interactions with the host immune system 2016 ·Current Opinion in Virology ·Dipongkor Saha, Hiroaki Wakimoto, Samuel D. Rabkin	48
14	Exploring the antitumor effect of virus in malignant glioma 2015 ·Drugs of the Future ·Dipongkor Saha, Seemin Seher Ahmed, Samuel D. Rabkin	23
15	Unusual outcome of in utero infection and subsequent postnatal super-infection with different PCV2b strains 2014 ·Virologica Sinica ·Dipongkor Saha, Uladzimir Karniychuk, Liping Huang, Marc Geldhof, Merijn Vanhee, David Lefebvre, Peter Meerts, Richard Ducatelle, Jan Van Doorsselaere, Hans Nauwynck	6
16	Impact of a novel inactivated PRRS virus vaccine on virus replication and virus-induced pathology in fetal implantation sites and fetuses upon challenge 2012 ·Theriogenology ·Uladzimir Karniychuk, Dipongkor Saha, Merijn Vanhee, Marc Geldhof, Pieter Cornillie, (unknown), Nick De Regge, Hans Nauwynck	35
17	Porcine reproductive and respiratory syndrome virus (PRRSV) causes apoptosis during its replication in fetal implantation sites 2011 ·Microbial Pathogenesis ·Uladzimir Karniychuk, Dipongkor Saha, Marc Geldhof, Merijn Vanhee, Pieter Cornillie, Wim Van Den Broeck, Hans Nauwynck	92
18	Instability in vitro of a PCV2 infectious clone containing an insertion between ORF1 and ORF2 2011 ·Virus Genes ·Dipongkor Saha, Jan Van Doorsselaere, Hans Nauwynck	4
19	Outcome of experimental porcine circovirus type 1 infections in mid-gestational porcine foetuses 2011 ·BMC Veterinary Research ·Dipongkor Saha, David Lefebvre, Richard Ducatelle, Jan Van Doorsselaere, Hans Nauwynck	31
20	Antigenic subtyping and epitopes’ competition analysis of porcine circovirus type 2 using monoclonal antibodies 2011 ·Veterinary Microbiology ·Dipongkor Saha, Liping Huang, E Bussalleu, David Lefebvre, María Fort, Jan Van Doorsselaere, Hans Nauwynck	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact